Ascendis Pharma AS
Biotechnology
Healthcare
ASND
59.76 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
133.57
52 week high
168.84
high
153.49
52 week low
112.93
low
124.06
growth
2.03 %
previous Close
137.41
P/E ratio
-80
market cap
8.16 B
div yield
0
usd
Sep 2024
qoq
revenue
57.83 M
60.66 %
net incoming
-99.20 M
9.31 %
eps
-1.72 %
18.48 %
eps surprise
8.99 %
net profit margin
-171.52 %
132.00 %
operating incoming
-96.74 M
27.40 %
net change in cash
0.00 %
cash on hand
626 M
141.80 %
cost of revenue
11.20 M
-2.30 %
top top